Wash U Team Aims to Develop Sequencing-Based Individualized Vaccines for Breast Cancers

The team plans to use sequencing to create a polyepitope DNA vaccine that will contain "fragments from each individual mutated protein" for individual patients. They hope to begin human trials for the vaccine within the next two years.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.